Abstract
To analyze the frequency and clinical characteristics of patients with amyotrophic lateral sclerosis (ALS) with intermediate-length (CAG) expansion (encoding 27-33 glutamines, polyQ) in the ATXN2 gene, in a population-based cohort of Italian patients with ALS (discovery cohort), and to replicate the findings in an independent cohort of consecutive patients from an ALS tertiary center (validation cohort).
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 251-258 |
| Numero di pagine | 8 |
| Rivista | Neurology |
| Volume | 84 |
| Numero di pubblicazione | 3 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2015 |
All Science Journal Classification (ASJC) codes
- Neurologia (clinica)
Keywords
- als
Fingerprint
Entra nei temi di ricerca di 'ATXN2 polyQ intermediate repeats are a modifier of ALS survival'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver